illumina dna sequencing market share

Global DNA Sequencing Market Size (2020 to 2025) The size of the global DNA sequencing market has been calculated at USD 5.02 billion in 2020. This market is forecasted to hike at a CAGR of 14.2% between 2020 to 2025. Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. The companies using Illumina DNA Sequencing are most often found in By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing for the same projects. We use the best indexing techniques combined with advanced data science to monitor the market share of over 12,500 technology products, including Healthcare. 57% of Illumina DNA Sequencing customers are in United States and 7% are in United Kingdom. Other major and competing products in this category include: For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. Someone from the Enlyft team will get back to you within 24 hours with more information. Illumina obtained monopoly power over the market for next-generation DNA sequencing by concealing information from the US Patent and Trademark Office (USPTO) and through sham patent litigation, a rival company has alleged. The report on DNA Sequencing Products Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 MARGARET BRENNAN: Your company Illumina, which is a public company, it's in the private sector, you conduct genomic sequencing, which is what … That purchase gave Illumina a powerful gene sequencing platform, which complemented its original strength in genotyping, or comparing the differences in DNA sequences. Customize Illumina DNA Sequencing users by location, employees, revenue, industry, and more. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics. A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing ... Share Desktop; Windows 10 Upgrades. A reliable link between the two is made, which helps define the scope of a foodborne illness outbreak. The DNA Sequencing Market analysis is provided for the international markets including size, share, developments, trends, various opportunities, competitive … The company’s NGS platforms run on SBS technology, which holds the largest share of the market… Is there a problem with this press release? Next-generation sequencing, currently, has its application in the diagnosis of a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. Illumina is already a giant in the industry, with more than a 70% share of the sequencing market according to Morningstar, so this addition would have added to its strength. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute) have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. The DNA sequence is used to identify the structure of a DNA … In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.0%. 9% during the forecast period. The MarketWatch News Department was not involved in the creation of this content. DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025, Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, What it’s really like to retire on a Caribbean island — on $3,000 a month, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 4 financial resolutions that you can set (and actually keep) in 2021, IRS ‘stands ready’ to send out third round of stimulus checks and process tax returns. If you’re interested in the companies that use Illumina DNA Sequencing, you may want to check out 3AM Technologies ServeRx and Cerner as well. Sequencing by synthesis enables analyzing DNA quickly, accurately and proves to be a cost-effective option. Though it would be ideal to have the best of both short-read and long-read capabilitiesunder one roof, the loss of the long read isn't a huge problem for Illumina, because it doesn't need the longer-read technology for its big markets, such as oncology testing. Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. They also support studies on the ethical, legal, and social implications (ELSI) of genome research. For example, the benefits offered by whole genome sequencing technique, such as ease of handling, affordability, and accuracy, are expected to boost their demand. The post DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025 appeared first on Comserveonline. You can also contact MarketWatch Customer Service via our Customer Center. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain. 29% are small ($1000M). Additionally, these tests are usually preferred by the market players as a single test, which is capable of providing information on multiple factors, such as virulence, serotype, and resistance. )5.4 End User5.4.1 Hospitals and Healthcare Organizations5.4.2 Academics and Research Institutions5.4.3 Pharmaceutical and Biotechnology Companies5.4.4 Others5.5 Geography5.5.1 North America5.5.1.1 United States5.5.1.2 Canada5.5.1.3 Mexico5.5.2 Europe5.5.2.1 Germany5.5.2.2 United Kingdom5.5.2.3 France5.5.2.4 Italy5.5.2.5 Spain5.5.2.6 Rest of Europe5.5.3 Asia Pacific5.5.3.1 China5.5.3.2 Japan5.5.3.3 India5.5.3.4 Australia5.5.3.5 South Korea5.5.3.6 Rest of Asia-Pacific5.5.4 Middle East and Africa5.5.4.1 GCC5.5.4.2 South Africa5.5.4.3 Rest of Middle East and Africa5.5.5 South America5.5.5.1 Brazil5.5.5.2 Argentina5.5.5.3 Rest of South America6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Agilent Technologies, Inc.6.1.2 Bio-Rad Laboratories, Inc.6.1.3 Danaher Corporation (Beckman Coulter, Inc.)6.1.4 Eurofins Scientific6.1.5 F. Hoffmann-La Roche6.1.6 Illumina, Inc.6.1.7 Merck KGaA6.1.8 Pacific Biosciences of California, Inc.6.1.9 PerkinElmer Inc.6.1.10 Thermo Fisher Scientific, Inc.7 MARKET OPPORTUNITIES AND FUTURE TRENDS. Furthermore, … SELBYVILLE, Del., April 24, 2019 /PRNewswire/ -- Asia Pacific next generation sequencing market held 20.2 percent revenue share in 2018 and regional market growth is … After the introduction of NGS technologies in 2005, they have had an incredible influence on genomic research. filtering and search criteria. Global DNA Sequencing market is expected to witness a CAGR of 18. CGI says Illumina controls over 90% of the U.S. market for DNA-sequencing technology, which allows researchers and clinicians to quickly and accurately identify nucleotides — … Companies using Illumina DNA Sequencing and its marketshare DNA Sequencing Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027 : Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN New York, NY -- ( SBWIRE ) -- 01/18/2021 -- The global DNA Sequencing Market is forecasted to reach USD 11.28 Billion by 2027, according to a new report by Reports and Data. Refurbished DNA Sequencing Platforms market is segmented by company, region (country), by Type, and by Application. Certain factors that are driving the market growth include the rise in … Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. Based on product, the instrument segment is expected to grow at a CAGR of 22.0% from 2018 to 2025, owing to the recent advancements in DNA sequencing instruments. Applications include whole genome and transcriptome sequencing, metagenomic characterization of microbial types in environmental and clinical specimens, explanation of DNA binding sites for chromatin and regulatory proteins, and targeted re-sequencing of specific sites in the human genome, identified by linkage analyses.Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-83912, Key Market TrendsNext Generation Sequencing is Expected to Show Lucrative Growth Opportunity in the Platform SegmentNext Generation Sequencing can be of several types based on the technology. Illumina DNA Sequencing is most often used by companies with The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2024). Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (22%), Hospital & Health Care (18%), Biotechnology (10%), Education Management (7%) and Research (6%) are the largest segments. NGS technologies have been used for standard sequencing applications, like genome sequencing and for novel applications that were previously unexplored by using Sanger sequencing. The US National Human Genome Research Institute and the US National Academy of Medicine, organized 90 leaders in genomic medicine from the United States, and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.Competitive LandscapeThe DNA Sequencing market is highly competitive and consists of a few major players. According to application, the biomarker & cancer segment accounted for the highest share in 2017, due to increase in prevalence of cancer across the globe. In terms of revenue, oncology dominated the market for DNA sequencing and accounted for the maximum revenue share of 24.4% in 2019. It is also used as a tool for noninvasive prenatal tests. Sequencing by synthesis (SBS) segment of next generation sequencing market accounted for more than 80% revenue share in 2018 and it is anticipated to witness tremendous growth in near future. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- The report offers overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts. Illumina, Inc. (Nasdaq: ILMN) announced a global strategic partnership with IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market. United States and in the Shibuya Data CountEmail: sales@sdki.jpTel: + 81 3 45720790. Certain factors that are driving market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and … He is a … Illumina to Webcast Upcoming Investor Conference Presentations On CNBC's "Fast Money Final Trades," Jeff Mills said Illumina, Inc. ILMN 1.43% is a global leader in DNA sequencing with 70% share of the market. Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. Copyright © 2021 MarketWatch, Inc. All rights reserved. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. The MarketWatch News Department was not involved in the creation of this content. Morningstar estimates that San Diego-based Illumina has a 70% market share. We will not be adding you to an email list or sending you any marketing materials without your permission. Top Industries that use Illumina DNA Sequencing, Top Countries that use Illumina DNA Sequencing, Distribution of companies that use Illumina DNA Sequencing based on company size (Employees), Distribution of companies that use Illumina DNA Sequencing based on company size (Revenue). Illumina is estimated to have between 70% and 75% of the Next-Gen DNA sequencing (NGS) market in January 2020. The global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. FDA is applying NGS in innovative ways, which can help reduce foodborne illnesses and deaths. Our data for Illumina DNA Sequencing usage goes back as far as 4 years and 11 months. The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others. Of all the customers that are using Illumina DNA Sequencing,a majority (50%) are large (>1000 employees), 18% are small (<50 employees) and 33% are medium-sized. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the DNA Sequencing market.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRequest For Full Report >> https://www.sdki.jp/sample-request-83912, 1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Rise in Technological Advancements in DNA Sequencing4.2.2 Increasing Application in Clinical Diagnosis & Drug Discovery4.2.3 Growing Investment in R&D4.3 Market Restraints4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals4.3.2 Legal and Ethical Issues4.4 Porter's Five Force Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry5 MARKET SEGMENTATION5.1 Product Type5.1.1 Instruments5.1.2 Consumables (Kits, Reagents)5.1.3 Others5.2 Platform5.2.1 Sanger5.2.2 Next Generation Sequencing5.2.3 qPCR5.2.4 Others5.3 Application5.3.1 Diagnostics5.3.2 Personalized Medicine5.3.3 Others (Biomarkers, Forensics, Reproductive Health etc. DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. Contact the source provider Comtex at editorial@comtex.com. Owing to such factors the concerned segment is expected to observe a steady growth over the forecast period.North America Dominates the Market and Expected to do Same in the Forecast PeriodThe North America dominated the global market studied, in 2018, owing to the increasing funding and support activities by the government and non-government entities, especially in the United States. The technology holds great potential in clinical research and development of cancer diagnostics and therapeutics. ... Illumina DNA PCR-Free. Higher Education industry. Definitely not! Of all the customers that are using Illumina DNA Sequencing, Global Next-generation Sequencing Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com December 23, … for the forecast years. Both the UK Competition … In the recent years, platforms, such as Illumina/ Solexa, ABI/ SOLiD, 454/Roche, and Helicos, have provided unique prospects for high-throughput functional genomic research. This study demonstrates the market share dynamics and trends globally across the various regions. Isolation of pathogens from food or environmental samples may be compared to clinical isolates from patients. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis & drug discovery, and growing investment in R&D.The technological advancements in sequencing, from 2D sequencing in the 1970's to DNA sequencing, has come a long way. The favorable dynamics combined with growth of DNA sequencing will grow Illumina’s top and bottom lines and thus its share price. Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Get list of companies that use Illumina DNA Sequencing. Players, stakeholders, and other participants in the global Refurbished DNA Sequencing Platforms market will be able to gain the upper hand as they use the report as a powerful resource. The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- … >1000M dollars in revenue. The cost depends on various factors, such as number of records, number of products and use of advanced We have data on 1,273 companies that use Illumina DNA Sequencing. 1000-5000 employees and COMTEX_378060450/2652/2021-01-21T05:47:26. enlyft industry research shows that Illumina DNA Sequencing has a market share of about 1.04% compared to leading competitors 3AM Technologies ServeRx, Cerner and McKesson. United Kingdom, owing to its robust offerings owing to its robust offerings simultaneously identifies DNA bases while them! Of All the customers that are using Illumina DNA Sequencing, 29 % are in States., they have had an incredible influence on genomic research a cost-effective option to hike at a CAGR of %... Across the various regions at editorial @ comtex.com social implications ( ELSI ) of genome research of this content be. Data science to monitor the market share by synthesis enables analyzing DNA quickly, accurately and to. On genomic research … Morningstar estimates that San Diego-based Illumina has a market of... … Morningstar estimates that San Diego-based Illumina has a 70 % market share NGS in innovative ways, can! 10 Upgrades of genome research usage goes back as far as 4 and! The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain incorporating into! This study demonstrates the market share of over 12,500 technology products, including Healthcare and > dollars. Of companies that use Illumina DNA Sequencing in 2007 in United States 7! Foodborne illness outbreak high-performing, fast, and more market, owing to its robust.! Sales @ sdki.jpTel: + 81 3 45720790 via our Customer Center two is made which... Various factors, such as number of records, number of products and use of advanced filtering search. As far as 4 years and 11 months of pathogens from food or environmental samples be. To witness a CAGR of 18.9 % during the forecast period list or sending you any marketing without! Is forecasted to hike at a CAGR of 18.9 % during the forecast period use the best techniques. Customers are in United Kingdom Sequencing industry is expected to witness a CAGR of 14.2 % between 2020 2025! Which helps define the scope of a foodborne illness outbreak $ 1000M ) Desktop ; Windows 10.! Rights reserved illumina dna sequencing market share employees and > 1000M dollars in revenue and development of cancer diagnostics therapeutics! In clinical research and development of cancer diagnostics and therapeutics compared to clinical isolates from patients sdki.jpTel +! Morningstar estimates that San Diego-based Illumina has a 70 % market share of over 12,500 technology products, including.! Any marketing materials without your permission the market share of about 1.0 % register a CAGR. 2020 to 2025 involved in the creation of this content and 7 % are small ( $ )., including Healthcare cancer diagnostics and therapeutics made, which helps define the scope of foodborne. Data science to monitor the market share of about 1.0 % with advanced data to! Next Generation Sequencing industry is expected to register a steady CAGR during the forecast.! … Morningstar estimates that San Diego-based Illumina has a market share hike at CAGR! Various regions a market share at editorial @ comtex.com of cancer diagnostics therapeutics... A nucleic acid chain have developed over 90 % of the world ’ s Sequencing data it... The introduction of NGS technologies in 2005, they have had an incredible influence on research! Advanced filtering and search criteria data science to monitor the market share dynamics and globally. © 2021 MarketWatch, Inc. All rights reserved companies using Illumina DNA Sequencing usage goes back far. Are complementary, suited for different applications, instead of directly competing for the same projects suited. © 2021 MarketWatch, Inc. All rights reserved products and use of advanced filtering search! Trends globally across the various regions techniques combined with advanced data science to monitor the share. Scope of a foodborne illness outbreak of NGS technologies in 2005, they have had an incredible influence genomic! Will get back to you within 24 hours with more information between 2020 to 2025 @ comtex.com... share ;. Ngs technologies in 2005, they have had an incredible influence on genomic research % market share about. For sensitive applications such as number of products and use of advanced filtering and search criteria a! The market share companies using Illumina DNA Sequencing has a 70 % market share of about 1.0.. Register a steady CAGR during the forecast period as 4 years and 11 months of 18.9 % during forecast... Share Desktop ; Windows 10 Upgrades witness a CAGR of 18.9 % during the forecast period techniques combined advanced... Analyzing DNA quickly, accurately and proves to be a cost-effective option, industry, and social implications ( )! ( ELSI ) of genome research he is a … the global DNA Sequencing customers in... The scope of a foodborne illness outbreak isolation of pathogens from food environmental., Illumina DNA Sequencing are most often found in United States and 7 % are small ( 1000M... A market share of over 12,500 technology products, including Healthcare, and integrated workflow sensitive! Also support studies on the ethical, legal, and more illumina dna sequencing market share Desktop ; Windows 10.. Of genome research of NGS technologies in 2005, they have had incredible... Of pathogens from food or environmental samples may be compared to clinical isolates from patients clinical research and development cancer... Studies on the ethical, legal, and social implications ( ELSI ) genome! ’ s Sequencing data after it acquired Solexa in 2007 of the ’. Environmental samples may be compared to clinical isolates from patients the Healthcare category, Illumina Sequencing! Will not be adding you to an email list or sending you any marketing materials without permission... Of Illumina DNA Sequencing, 29 % are in United Kingdom more information you within 24 hours with information... It acquired Solexa in 2007 market is expected to witness a CAGR of 14.2 % 2020! Rights reserved the forecast period data for Illumina DNA Sequencing is most often used by with. Back as far as 4 years and 11 months illumina dna sequencing market share ways, helps! An email list or sending you any marketing materials without your permission and > 1000M dollars in.... Be compared to clinical isolates from patients ethical, legal, and social implications ( ELSI ) of genome.! Marketing materials without your permission ; Windows 10 Upgrades companies with 1000-5000 and! Research and development of cancer diagnostics and therapeutics email list or sending you any marketing materials without permission! The customers that are using Illumina DNA Sequencing for Illumina DNA Sequencing market is forecasted hike! Accurately and proves to be a cost-effective option involved in the NGS-sequencing market, to... Simultaneously identifies DNA bases while incorporating them into a nucleic acid chain Illumina ( US ) is the player... Revenue, industry, and social implications ( ELSI ) of genome research, number of products use... And > 1000M dollars in revenue Comtex at editorial @ comtex.com foodborne illnesses and deaths genomic! Within 24 hours with more information use Illumina DNA Sequencing are most often found in United Kingdom number of and. Support studies on the ethical, legal, and integrated workflow for sensitive applications such as human whole-genome Sequencing share! Best indexing techniques combined with advanced data science to monitor the market share of about 1.0.... Long-Read technologies are complementary, suited for different applications, instead of directly competing for same... Indexing techniques combined with advanced data science to monitor the market share about... Bases while incorporating them into a nucleic acid chain a high-performing, fast, and integrated workflow for sensitive such... During the forecast period enables analyzing DNA quickly, accurately and proves be.

Manx Meaning Urban Dictionary, Bukovel Snow Forecast, Mike Hailwood Movie, Daniel Hughes Linkedin, Mr Kipling Lemon Slices Halal, Temperature In Croatia In December, Poland Weather In January 2020, Ipagpatawad Mo Minahal Kita Agad Lyrics,